Back to results
US 8,709,469 B2Granted
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
AssigneeAbbott Cardiovascular Systems Inc.
InventorStephen Dugan
Life of this patent
Estimating the term…
Abstract
Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.
Claims5
A stent comprising:
- an effective amount of an anti-proliferative agent;
- a body structure, the body structure being made of a bioabsorbable polymer;
- and
- an effective amount of a steroidal anti-inflammatory agent or a non-steroidal anti-inflammatory agent mixed or dispersed throughout the body structure of the stent for the treatment of a vascular disorder or a related disorder.
1 more element
Dependencies are inferred from the claim text.